CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation

Updated : Jun 23, 2026 10:18
|
ANI

PRNewswire
Seoul [South Korea], June 23: Informa Markets Korea has officially opened pre-registration for CPHI/ Hi Korea 2026, taking place at COEX, Seoul, from August 25 to 27. Pre-registered visitors enjoy complimentary entries.
This year marks the largest edition to date, expanding across COEX Halls C, E and The Platz with exhibition space up approximately 14% year-on-year. Around 420 companies from over 70 countries will showcase their latest ingredients, products and technology solutions to an estimated 12,000+ industry professionals.
As the Korea edition of the global CPHI series, the show offers a truly international meeting point where pharma, bio, and nutraceutical players from around the world come together. Global companies network with one another, Korean players strengthening domestic partnerships, and cross-border collaborations forming in every direction. Underpinned by Korea's leading pharma manufacturing, advanced CDMO infrastructure, and fast-growing nutraceutical market, the show serves as a strategic platform for business across Asia and beyond.
Major government and industry organizations have stepped forward as sponsors, including the Ministry of Food and Drug Safety (MFDS), Korea Fund for Regenerative Medicine (KFRM), Korea Institute of Toxicology (KIT), Korea Health Functional Food Association (KHFF), Korea Drug Research Association (KDRA), Korea Invention Promotion Association (KIPA), and DIPS. The Bio Zone is co-organized with the Korea Biomedicine Industry Association (KoBIA).
Expanded Seminar & Conference Program
Reflecting strong industry interest, the conference program expands from 4 tracks last year to 6 tracks this year, offering broader coverage of the industry. Following last year's success, the K-Health Conference will cover MFDS-led discussions on personalized health functional food regulations.
On the bio and pharma side, dedicated sessions spotlight Korea's emerging K-platform technologies, including ADC, TPD, and RPT, and clinical trials, alongside the latest GLP-1-related developments. The program also features the Biohealth Policy Forum hosted by KDRA, offering further insights into industry policy direction and strategic priorities.
The conference also includes IR sessions, a Startup Challenge, and the Global Build-Up Program, supporting commercialization and market entry across Japan, China, Thailand, Malaysia, and the United States.
Hall E Nearing Sell-Out. Final Booth Applications
Hall E, secured to accommodate overflow demand, is also nearing full capacity. Companies considering participation are encouraged to apply early.
- Pre-registration: https://cphik.imasia-passport.com/bn50eD
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PRNewswire. ANI will not be responsible in any way for the content of the same)

(This article was generated from news agency ANI without modifications to the text.)

Recommended For You

editorji | Business

Honda Activa 6G: Everything You Need to Know Before Buying

editorji | Business

How much does a ULIP plan really cost? A break-down of all charges

editorji | Business

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

editorji | Business

Reliance denies buying Iranian oil amid US sanctions waiver

editorji | Business

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates